Substance Use Disorders. (A) Includes pharmacotherapy for adults diagnosed with opioid dependence, alcohol dependence, or nicotine dependence and without medical contraindications. Publicly funded programs will not discriminate in providing access to Services for Individuals using medications to treat and manage addictions.
Substance Use Disorders. (1) Contractor shall provide Substance Use Disorders services to Members, which include outpatient, intensive outpatient, medication assisted treatment including, Opiate Substitution Services, residential and detoxification treatment services. For purposes of this Contract, OHA rules and criteria applicable to outpatient treatment services are located in OAR Chapter 309, Divisions 18, 19 and 22, the OHA rules and criteria applicable to synthetic opiate treatment services located in OAR Chapter 415 Division 20, and the AMH rules and criteria applicable to detoxification centers located in OAR Chapter 415 Division 50. For technical assistance related to this section of this Contract, the OHA contact will be the Medicaid Substance Use Disorders Specialist.
Substance Use Disorders. “Substance Use Disorders” means disorders related to the taking of a drug of abuse including alcohol, to the side effects of a medication, or to a toxin exposure. The disorders include substance use disorders, such as substance dependence and substance abuse, and substance-induced disorders, such as substance intoxication, withdrawal, delirium, dementia, and substance-induced psychotic or mood disorder, as defined in DSM-V criteria.
Substance Use Disorders. Substance use disorders in the United States remain a significant national public health concern for healthcare providers, policymakers, community leaders, and health researchers. Data from NSDUH estimates that in 2012, among people 12 years of age and older, 22.2 million met the criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) for substance dependence or abuse. [4] This constitutes approximately 8.5% of entire the U.S. population. [4] Despite the high prevalence of SUD, there remains an exceptionally large substance abuse treatment gap in the U.S. For example, while 22.2 million people in 2012 met the criteria for SUD, only 4.0 million people reported receiving any type of substance abuse treatment. More specifically only 2.5 million people reported receiving substance abuse treatment in a specialty treatment setting. [4] These large treatment gaps pose alarming public health implications given that untreated SUD causes a variety physical and mental health issues ranging from depression [5-11], engagement in criminal and high-risk behaviors [12,13], and death. [14-18] Thus, identifying all possible barriers and inducements to seeking SUD treatment is an important public health priority. As with other areas of public health research, a growing body of literature is investigating the role of religion as a factor influencing the prevention and treatment of SUD.
